Trixeo Aerosphere 5/7.2/160 μg

Trixeo Aerosphere 5/7.2/160 μg is a medicine authorised by Swissmedic under authorisation number 68388. The authorisation holder is AstraZeneca AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 November 2021 and the authorisation is valid without a time limit. ATC code R03AL11 places the medicine in the group Drugs for obstructive airway diseases.

  • Dispensing category B
  • Authorisation number 68388
  • ATC R03AL11
  • Synthetic medicines
Authorisation data
Authorisation number68388
NameTrixeo Aerosphere 5/7.2/160 μg
Full nameTrixeo Aerosphere 5/7.2/160 μg, Druckgasinhalation, Suspension
Authorisation holderAstraZeneca AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeR03AL11
First authorisation24 November 2021
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Trixeo Aerosphere 5/7.2/160 μg, Druckgasinhalation, SuspensionB24 November 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
2120InhalationenR03AL1103.99.0.B
3360InhalationenR03AL1103.99.0.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Trixeo Aerosphere 5/7.2/160 μg authorised in Switzerland?

Yes. Trixeo Aerosphere 5/7.2/160 μg is authorised by Swissmedic under authorisation number 68388, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Trixeo Aerosphere 5/7.2/160 μg have?

Trixeo Aerosphere 5/7.2/160 μg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Trixeo Aerosphere 5/7.2/160 μg?

The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com